Cargando…
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
We investigated the mRNA expression levels of all six antiapoptotic Bcl-2 subfamily members in 68 human cancer cell lines using qPCR techniques and measured the ability of known Bcl-2 inhibitors to induce cell death in 36 of the studied tumor cell lines. Our study reveals that Mcl-1 represents the a...
Autores principales: | Placzek, W J, Wei, J, Kitada, S, Zhai, D, Reed, J C, Pellecchia, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032312/ https://www.ncbi.nlm.nih.gov/pubmed/21364647 http://dx.doi.org/10.1038/cddis.2010.18 |
Ejemplares similares
-
An Optically Pure Apogossypolone Derivative as Potent Pan-Active Inhibitor of Anti-Apoptotic Bcl-2 Family Proteins
por: Wei, Jun, et al.
Publicado: (2011) -
Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members
por: Cui, Jia, et al.
Publicado: (2018) -
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
por: Inoue-Yamauchi, Akane, et al.
Publicado: (2017) -
Anti-apoptotic BCL-2 family members in development
por: Opferman, Joseph T, et al.
Publicado: (2018) -
Apoptotic Protease Activating Factor 1 (Apaf-1)–Independent Cell Death Suppression by Bcl-2
por: Haraguchi, Misako, et al.
Publicado: (2000)